Baudax Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Baudax Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2023.
  • Baudax Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $3.21M, a 64.6% decline year-over-year.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18.4M, a 57.1% decline from 2021.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.9M, a 25.2% decline from 2020.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $57.3M, a 17.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $3.21M -$5.85M -64.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $9.06M -$12.9M -58.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $21.9M -$4.94M -18.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $26.9M +$12M +81.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $14.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.